Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF

J Am Coll Cardiol. 2020 Nov 17;76(20):2417-2418. doi: 10.1016/j.jacc.2020.09.551.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Aminobutyrates
  • Biomarkers
  • Biphenyl Compounds
  • Drug Combinations
  • Extracellular Matrix
  • Heart Failure* / diagnosis
  • Humans
  • Stroke Volume
  • Tetrazoles
  • Valsartan

Substances

  • Aminobutyrates
  • Biomarkers
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination